Mirae Asset Global ETFs Holdings’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,415
Closed -$43.9K 3046
2025
Q1
$43.9K Buy
2,415
+110
+5% +$3.14K ﹤0.01% 2871
2024
Q4
$85.5K Buy
2,305
+99
+4% +$3.79K ﹤0.01% 2762
2024
Q3
$70.6K Buy
2,206
+416
+23% +$23.1K ﹤0.01% 2837
2024
Q2
$147K Buy
+1,790
New +$194K ﹤0.01% 2406

Other funds holding CDLX

Mirae Asset Global ETFs Holdings's CDLX Position: Q2 2025 in Review

Mirae Asset Global ETFs Holdings sold out of Cardlytics (CDLX) in Q2 2025, closing a stake of 2,415 shares — an estimated $43.9K sold.

Mirae Asset Global ETFs Holdings first reported a position in CDLX in Q2 2024 and held it in 4 quarters. The position peaked at $147K in Q2 2024. 89 funds tracked by Wall St. Rank hold CDLX as of Q2 2025.

  • Mirae Asset Global ETFs Holdings reported no remaining Cardlytics position as of Q2 2025 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 2,415 Cardlytics shares in Q2 2025, an estimated $43.9K.
  • Mirae Asset Global ETFs Holdings first reported a position in Cardlytics in Q2 2024 and held it in 4 quarters.
  • Mirae Asset Global ETFs Holdings's Cardlytics position peaked at $147K in Q2 2024.
  • 89 funds tracked by Wall St. Rank held Cardlytics as of Q2 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.